Sentry Investment Management LLC Cuts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sentry Investment Management LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,423 shares of the medical equipment provider’s stock after selling 488 shares during the period. Intuitive Surgical comprises about 0.6% of Sentry Investment Management LLC’s portfolio, making the stock its 27th largest holding. Sentry Investment Management LLC’s holdings in Intuitive Surgical were worth $1,265,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently made changes to their positions in the company. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the fourth quarter worth $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $28,000. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the fourth quarter valued at about $36,000. Finally, Sierra Ocean LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth about $40,000. 83.64% of the stock is owned by institutional investors.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company’s stock, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. The trade was a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,240 shares of company stock worth $3,529,040 in the last three months. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Truist Financial boosted their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Citigroup upped their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Royal Bank of Canada upped their price target on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Finally, CICC Research started coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price target for the company. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Trading Down 0.1 %

Shares of NASDAQ:ISRG opened at $591.01 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market cap of $210.51 billion, a P/E ratio of 92.20, a P/E/G ratio of 5.85 and a beta of 1.39. The company has a 50 day moving average of $566.43 and a 200 day moving average of $526.49.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.